Ceftazidime-Avibactam Regimens for the Treatment of Bacteremic and Non-Bacteremic Episodes of Carbapenemase-Producing Enterobacterales Infections in Immunosuppressed Patients

Ceftazidime-avibactam (CA) and CA plus aztreonam (ATM) are the preferred treatment options for KPC and MBL carbapenemase-producing Enterobacterales infections (CPEis). All episodes of monomicrobial CPEis in immunosuppressed patients (IPs) admitted from May 2019 to November 2024, who received definit...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Fabián Herrera, Diego Torres, María Leone, Maximiliano Gabriel Castro, Jorge López Camelo, Elena Temporiti, Natalin Grippo, Silvia Relloso, Pablo Bonvehí
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-12-01
Schriftenreihe:	Pathogens
Schlagworte:	ceftazidime-avibactam carbapenemase-producing enterobacterales immunosuppressed patients
Online-Zugang:	https://www.mdpi.com/2076-0817/14/12/1300
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!